Balchem Corporation Announces Dividend
Rhea-AI Summary
Balchem (NASDAQ: BCPC) announced that on Dec 9, 2025 its board declared an annual dividend of $0.96 per share, payable Jan 20, 2026 to holders of record at the close of business on Dec 23, 2025.
The dividend equals a 10.3% increase versus last year and marks the seventeenth consecutive annual dividend increase, which management links to sustained financial performance and board confidence in long-term strategy.
Positive
- Dividend set at $0.96 per share
- 10.3% year-over-year increase in annual dividend
- Seventeenth consecutive annual dividend increase
- Payable on Jan 20, 2026 to holders of record on Dec 23, 2025
Negative
- Company will incur a cash outflow when the $0.96 per-share dividend is paid on Jan 20, 2026
News Market Reaction 4 Alerts
On the day this news was published, BCPC gained 2.35%, reflecting a moderate positive market reaction. Our momentum scanner triggered 4 alerts that day, indicating moderate trading interest and price volatility. This price movement added approximately $118M to the company's valuation, bringing the market cap to $5.15B at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
BCPC gained 2.35% while peers were mixed: SXT +1.67%, ESI +4.19%, SSL +1.45%, AXTA +3.27%, CBT -0.06%, pointing to a company-specific response to the dividend news.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 10 | Dividend announcement | Positive | +2.4% | Board declared a higher annual dividend of $0.96 per share. |
| Oct 30 | Conference participation | Neutral | +0.2% | Planned presentation at Baird industrial conference with key executives. |
| Oct 21 | Earnings results | Positive | +4.1% | Q3 2025 showed higher sales, earnings, EBITDA, and strong cash flow. |
| Oct 07 | Earnings call notice | Neutral | -1.4% | Scheduled Q3 2025 earnings call and release timing details. |
| Aug 26 | Conference participation | Neutral | +0.2% | Announcement of participation in H.C. Wainwright investment conference. |
BCPC has shown stronger positive reactions to fundamental updates like earnings and dividend actions, while conference-related news has produced only modest or mixed moves.
Over the last several months, Balchem reported solid Q3 2025 growth, with higher net sales, earnings, and cash flow, alongside debt reduction and share repurchases, as detailed in the Oct 21, 2025 earnings release. Conference participation in August and October 2025 drew only small price changes. The newly announced $0.96 annual dividend, a 10.3% increase and seventeenth consecutive raise, fits a narrative of consistent financial performance and shareholder returns, which aligned with a 2.35% gain.
Market Pulse Summary
This announcement detailed a higher annual dividend of $0.96 per share, a 10.3% increase and the seventeenth consecutive raise, underscoring Balchem’s emphasis on shareholder returns and consistent financial performance. It follows strong Q3 2025 results with growing sales, earnings and cash flow, as well as ongoing debt reduction. Investors may watch how future earnings, cash generation, and capital allocation decisions support maintaining or extending this dividend growth record.
AI-generated analysis. Not financial advice.
MONTVALE, N.J., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that on December 9, 2025, its Board of Directors declared a dividend on its shares of common stock equal to
Ted Harris, Balchem’s Chairman, President and CEO, said, “Balchem has a longstanding commitment to an annual dividend and we are pleased to announce the continuation of that commitment. This dividend represents the seventeenth consecutive increase in our annual dividend, reflecting both the consistently outstanding financial performance the company has delivered and the Board’s continued confidence in our long-term strategies.”
About Balchem Corporation
Balchem Corporation develops, manufactures and markets specialty ingredients that improve and enhance the health and well-being of life on the planet, providing state-of the-art solutions and the finest quality products for a range of industries worldwide. The company reports three business segments: Human Nutrition & Health; Animal Nutrition & Health; and Specialty Products. The Human Nutrition & Health segment delivers customized food and beverage ingredient systems, as well as key nutrients into a variety of applications across the food, supplement and pharmaceutical industries. The Animal Nutrition & Health segment manufactures and supplies products to numerous animal health markets. Through Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries, and also provides chelated minerals to the micronutrient agricultural market.
Forward-Looking Statements
This release contains forward-looking statements, which reflect Balchem’s expectation or belief concerning future events that involve risks and uncertainties. Balchem can give no assurance that the expectations reflected in forward-looking statements will prove correct and various factors could cause results to differ materially from Balchem’s expectations, including risks and factors identified in Balchem’s Annual Report on Form 10-K for the year ended December 31, 2024 and other factors that may be identified in our other SEC filings. Forward-looking statements are qualified in their entirety by the above cautionary 2 statement. Balchem assumes no obligation to update or revise any forward-looking statements as of any future date.
Contact:
Jacqueline Yarmolowicz
Balchem Corporation (Telephone: 845-326-5600)
FAQ
What dividend did Balchem (BCPC) declare on Dec 9, 2025?
When is Balchem's (BCPC) dividend payable and what is the record date?
How much did Balchem's (BCPC) 2026 dividend increase versus last year?
How many consecutive annual dividend increases has Balchem (BCPC) announced?
What does the Balchem (BCPC) dividend announcement indicate about management's view?
